{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:48:41Z","timestamp":1791143321796,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1038\/sj.bjc.6603290","type":"journal-article","created":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T20:09:21Z","timestamp":1154462961000},"page":"561-570","source":"Crossref","is-referenced-by-count":55,"title":["Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy"],"prefix":"10.1038","volume":"95","author":[{"given":"S","family":"Sakano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Ohmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,8,1]]},"reference":[{"key":"BF6603290_CR1","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/jnci\/94.14.1091","volume":"94","author":"CH Bosken","year":"2002","unstructured":"Bosken CH, Wei Q, Amos CI, Spitz MR (2002) An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer. J Natl Cancer Inst 94: 1091\u20131099","journal-title":"J Natl Cancer Inst"},{"key":"BF6603290_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ijrobp.2004.09.047","volume":"62","author":"A Chakravarti","year":"2005","unstructured":"Chakravarti A, Winter K, Wu CL, Kaufman D, Hammond E, Parliament M, Tester W, Hagan M, Grignon D, Heney N, Pollack A, Sandler H, Shipley W (2005) Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: a report from the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 62: 309\u2013317","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF6603290_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/ssu.1013","volume":"20","author":"J Dunst","year":"2001","unstructured":"Dunst J, Rodel C, Zietman A, Schrott KM, Sauer R, Shipley WU (2001) Bladder preservation in muscle-invasive bladder cancer by conservative surgery and radiochemotherapy. Semin Surg Oncol 20: 24\u201332","journal-title":"Semin Surg Oncol"},{"key":"BF6603290_CR4","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1002\/cncr.20200","volume":"100","author":"X Garcia del Muro","year":"2004","unstructured":"Garcia del Muro X, Condom E, Vigues F, Castellsague X, Figures A, Munoz J, Sola J, Soler T, Capella G, Germa JR (2004) p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach. Cancer 100: 1859\u20131867","journal-title":"Cancer"},{"key":"BF6603290_CR5","first-page":"1513","volume":"11","author":"EL Goode","year":"2002","unstructured":"Goode EL, Ulrich CM, Potter JD (2002) Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11: 1513\u20131530","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF6603290_CR6","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1158\/1078-0432.CCR-04-1101","volume":"11","author":"J Gu","year":"2005","unstructured":"Gu J, Zhao H, Dinney CP, Zhu Y, Leibovici D, Bermejo CE, Grossman HB, Wu X (2005) Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer. Clin Cancer Res 11: 1408\u20131415","journal-title":"Clin Cancer Res"},{"key":"BF6603290_CR7","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1200\/JCO.2004.08.067","volume":"22","author":"S Gurubhagavatula","year":"2004","unstructured":"Gurubhagavatula S, Liu G, Park S, Zhou W, Su L, Wain JC, Lynch TJ, Neuberg DS, Christiani DC (2004) XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy. J Clin Oncol 22: 2594\u20132601","journal-title":"J Clin Oncol"},{"key":"BF6603290_CR8","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/35077232","volume":"411","author":"JH Hoeijmakers","year":"2001","unstructured":"Hoeijmakers JH (2001) Genome maintenance mechanisms for preventing cancer. Nature 411: 366\u2013374","journal-title":"Nature"},{"key":"BF6603290_CR9","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1093\/carcin\/22.6.917","volume":"22","author":"JJ Hu","year":"2001","unstructured":"Hu JJ, Smith TR, Miller MS, Mohrenweiser HW, Golden A, Case LD (2001) Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis 22: 917\u2013922","journal-title":"Carcinogenesis"},{"key":"BF6603290_CR10","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1200\/JCO.1997.15.3.1022","volume":"15","author":"LA Kachnic","year":"1997","unstructured":"Kachnic LA, Kaufman DS, Heney NM, Althausen AF, Griffin PP, Zietman AL, Shipley WU (1997) Bladder preservation by combined modality therapy for invasive bladder cancer. J Clin Oncol 15: 1022\u20131029","journal-title":"J Clin Oncol"},{"key":"BF6603290_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/85798","volume":"27","author":"KK Khanna","year":"2001","unstructured":"Khanna KK, Jackson SP (2001) DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 27: 247\u2013254","journal-title":"Nat Genet"},{"key":"BF6603290_CR12","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/ijc.10870","volume":"103","author":"R Kumar","year":"2003","unstructured":"Kumar R, Hoglund L, Zhao C, Forsti A, Snellman E, Hemminki K (2003) Single nucleotide polymorphisms in the XPG gene: determination of role in DNA repair and breast cancer risk. Int J Cancer 103: 671\u2013675","journal-title":"Int J Cancer"},{"key":"BF6603290_CR13","first-page":"2557","volume":"59","author":"RM Lunn","year":"1999","unstructured":"Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA (1999) XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 59: 2557\u20132561","journal-title":"Cancer Res"},{"key":"BF6603290_CR14","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/sj.bjc.6602073","volume":"91","author":"H Matsumoto","year":"2004","unstructured":"Matsumoto H, Matsuyama H, Fukunaga K, Yoshihiro S, Wada T, Naito K (2004a) Allelic imbalance at 1p36 may predict prognosis of chemoradiation therapy for bladder preservation in patients with invasive bladder cancer. Br J Cancer 91: 1025\u20131031","journal-title":"Br J Cancer"},{"key":"BF6603290_CR15","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/jjco\/hyh026","volume":"34","author":"H Matsumoto","year":"2004","unstructured":"Matsumoto H, Wada T, Fukunaga K, Yoshihiro S, Matsuyama H, Naito K (2004b) Bax to Bcl-2 ratio and Ki-67 index are useful predictors of neoadjuvant chemoradiation therapy in bladder cancer. Jpn J Clin Oncol 34: 124\u2013130","journal-title":"Jpn J Clin Oncol"},{"key":"BF6603290_CR16","first-page":"674","volume":"12","author":"G Matullo","year":"2003","unstructured":"Matullo G, Peluso M, Polidoro S, Guarrera S, Munnia A, Krogh V, Masala G, Berrino F, Panico S, Tumino R, Vineis P, Palli D (2003) Combination of DNA repair gene single nucleotide polymorphisms and increased levels of DNA adducts in a population-based study. Cancer Epidemiol Biomarkers Prev 12: 674\u2013677","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF6603290_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000132829","volume":"52","author":"HW Mohrenweiser","year":"1989","unstructured":"Mohrenweiser HW, Carrano AV, Fertitta A, Perry B, Thompson LH, Tucker JD, Weber CA (1989) Refined mapping of the three DNA repair genes, ERCC1, ERCC2, and XRCC1, on human chromosome 19. Cytogenet Cell Genet 52: 11\u201314","journal-title":"Cytogenet Cell Genet"},{"key":"BF6603290_CR18","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/S0022-5347(05)67522-2","volume":"163","author":"ML Paik","year":"2000","unstructured":"Paik ML, Scolieri MJ, Brown SL, Spirnak JP, Resnick MI (2000) Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy. J Urol 163: 1693\u20131696","journal-title":"J Urol"},{"key":"BF6603290_CR19","first-page":"8654","volume":"61","author":"DJ Park","year":"2001","unstructured":"Park DJ, Stoehlmacher J, Zhang W, Tsao-Wei DD, Groshen S, Lenz HJ (2001) A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer. Cancer Res 61: 8654\u20138658","journal-title":"Cancer Res"},{"key":"BF6603290_CR20","doi-asserted-by":"publisher","first-page":"5024","DOI":"10.1073\/pnas.84.14.5024","volume":"84","author":"E Reed","year":"1987","unstructured":"Reed E, Ozols RF, Tarone R, Yuspa SH, Poirier MC (1987) Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy. Proc Natl Acad Sci USA 84: 5024\u20135028","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6603290_CR21","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1200\/JCO.2002.11.027","volume":"20","author":"C R\u00f6del","year":"2002","unstructured":"R\u00f6del C, Grabenbauer GG, Kuhn R, Papadopoulos T, Dunst J, Meyer M, Schrott KM, Sauer R (2002) Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J Clin Oncol 20: 3061\u20133071","journal-title":"J Clin Oncol"},{"key":"BF6603290_CR22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.lungcan.2003.11.019","volume":"44","author":"JS Ryu","year":"2004","unstructured":"Ryu JS, Hong YC, Han HS, Lee JE, Kim S, Park YM, Kim YC, Hwang TS (2004) Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy. Lung Cancer 44: 311\u2013316","journal-title":"Lung Cancer"},{"key":"BF6603290_CR23","doi-asserted-by":"publisher","first-page":"6205","DOI":"10.1158\/1078-0432.CCR-05-0045","volume":"11","author":"SC Sak","year":"2005","unstructured":"Sak SC, Harnden P, Johnston CF, Paul AB, Kiltie AE (2005) APE1 and XRCC1 protein expression levels predict cancer-specific survival following radical radiotherapy in bladder cancer. Clin Cancer Res 11: 6205\u20136211","journal-title":"Clin Cancer Res"},{"key":"BF6603290_CR24","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/ijc.10919","volume":"104","author":"S Sakano","year":"2003","unstructured":"Sakano S, Berggren P, Kumar R, Steineck G, Adolfsson J, Onel\u00f6v E, Hemminki K, Larsson P (2003) Clinical course of bladder neoplasms and single nucleotide polymorphisms in the CDKN2A gene. Int J Cancer 104: 98\u2013103","journal-title":"Int J Cancer"},{"key":"BF6603290_CR25","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/j.1464-410X.2005.05994.x","volume":"97","author":"S Sakano","year":"2006","unstructured":"Sakano S, Kumar R, Larsson P, Onel\u00f6v E, Adolfsson J, Steineck G, Hemminki K (2006) A single-nucleotide polymorphism in the XPG gene, and tumour stage, grade, and clinical course in patients with nonmuscle-invasive neoplasms of the urinary bladder. BJU Int 97: 847\u2013851","journal-title":"BJU Int"},{"key":"BF6603290_CR26","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1093\/carcin\/bgh058","volume":"25","author":"S Sanyal","year":"2004","unstructured":"Sanyal S, Festa F, Sakano S, Zhang Z, Steineck G, Norming U, Wijkstrom H, Larsson P, Kumar R, Hemminki K (2004) Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 25: 729\u2013734","journal-title":"Carcinogenesis"},{"issue":"Suppl 11","key":"BF6603290_CR27","first-page":"2","volume":"19","author":"RL Schilsky","year":"1992","unstructured":"Schilsky RL (1992) Biochemical pharmacology of chemotherapeutic drugs used as radiation enhancers. Semin Oncol 19 (Suppl 11): 2\u20137","journal-title":"Semin Oncol"},{"key":"BF6603290_CR28","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1002\/cncr.11282","volume":"97","author":"WU Shipley","year":"2003","unstructured":"Shipley WU, Kaufman DS, Tester WJ, Pilepich MV, Sandler HM, Radiation Therapy Oncology Group (2003) Overview of bladder cancer trials in the Radiation Therapy Oncology Group. Cancer 97: 2115\u20132119","journal-title":"Cancer"},{"key":"BF6603290_CR29","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1001\/jama.1987.03400070069037","volume":"258","author":"WU Shipley","year":"1987","unstructured":"Shipley WU, Prout Jr GR, Einstein AB, Coombs LJ, Wajsman Z, Soloway MS, Englander L, Barton BA, Hafermann MD (1987) Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery. JAMA 258: 931\u2013935","journal-title":"JAMA"},{"key":"BF6603290_CR30","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1200\/JCO.1998.16.11.3576","volume":"16","author":"WU Shipley","year":"1998","unstructured":"Shipley WU, Winter KA, Kaufman DS, Lee WR, Heney NM, Tester WR, Donnelly BJ, Venner PM, Perez CA, Murray KJ, Doggett RS, True LD (1998) Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03. J Clin Oncol 16: 3576\u20133583","journal-title":"J Clin Oncol"},{"key":"BF6603290_CR31","first-page":"1354","volume":"61","author":"MR Spitz","year":"2001","unstructured":"Spitz MR, Wu X, Wang Y, Wang LE, Shete S, Amos CI, Guo Z, Lei L, Mohrenweiser H, Wei Q (2001) Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res 61: 1354\u20131357","journal-title":"Cancer Res"},{"key":"BF6603290_CR32","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/sj.bjc.6601975","volume":"91","author":"J Stoehlmacher","year":"2004","unstructured":"Stoehlmacher J, Park DJ, Zhang W, Yang D, Groshen S, Zahedy S, Lenz HJ (2004) A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU\/oxaliplatin combination chemotherapy in refractory colorectal cancer. Br J Cancer 91: 344\u2013354","journal-title":"Br J Cancer"},{"key":"BF6603290_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1200\/JCO.1996.14.1.119","volume":"14","author":"W Tester","year":"1996","unstructured":"Tester W, Caplan R, Heaney J, Venner P, Whittington R, Byhardt R, True L, Shipley W (1996) Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802. J Clin Oncol 14: 119\u2013126","journal-title":"J Clin Oncol"},{"key":"BF6603290_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0921-8777(99)00058-0","volume":"459","author":"LH Thompson","year":"2000","unstructured":"Thompson LH, West MG (2000) XRCC1 keeps DNA from getting stranded. Mutat Res 459: 1\u201318","journal-title":"Mutat Res"},{"key":"BF6603290_CR35","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/carcin\/bgh064","volume":"25","author":"P Vodicka","year":"2004","unstructured":"Vodicka P, Kumar R, Stetina R, Sanyal S, Soucek P, Haufroid V, Dusinska M, Kuricova M, Zamecnikova M, Musak L, Buchancova J, Norppa H, Hirvonen A, Vodickova L, Naccarati A, Matousu Z, Hemminki K (2004) Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. Carcinogenesis 25: 757\u2013763","journal-title":"Carcinogenesis"},{"key":"BF6603290_CR36","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.ijrobp.2005.07.951","volume":"63","author":"SM Yoon","year":"2005","unstructured":"Yoon SM, Hong YC, Park HJ, Lee JE, Kim SY, Kim JH, Lee SW, Park SY, Lee JS, Choi EK (2005) The polymorphism and haplotypes of XRCC1 and survival of non-small-cell lung cancer after radiotherapy. Int J Radiat Oncol Biol Phys 63: 885\u2013891","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF6603290_CR37","doi-asserted-by":"publisher","first-page":"4939","DOI":"10.1158\/1078-0432.CCR-04-0247","volume":"10","author":"W Zhou","year":"2004","unstructured":"Zhou W, Gurubhagavatula S, Liu G, Park S, Neuberg DS, Wain JC, Lynch TJ, Su L, Christiani DC (2004) Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. Clin Cancer Res 10: 4939\u20134943","journal-title":"Clin Cancer Res"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6603290.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6603290","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6603290.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:22:40Z","timestamp":1684412560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6603290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,1]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["BF6603290"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6603290","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,1]]}}}